Drugs / fluorine-18 fluorocholine
fluorine-18 fluorocholine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT00928174 | Jun 2009 → Jul 2013 | prostate cancer | Queen's Medical Center | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | fluorine-18 fluorocholine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00928174 ↗ |
| Modality | Diagnostic / imaging agent | “using fluorine-18 fluorocholine as an imaging agent” NCT00928174 ↗ |
| Route | Intravenous | “Fluorine-18 fluorocholine IV” NCT00928174 ↗ |